Results 181 to 190 of about 154,825 (291)

LncRNA TUSC7 Inhibits Cell Proliferation in Chronic Lymphocytic Leukemia by Modulating the miR‐211‐5p/SLC37A3 Axis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Chronic lymphocytic leukemia (CLL) is a malignant lymphoproliferative disorder. Long non‐coding RNAs (lncRNAs) have been implicated in various regulatory processes and cancer development. Among these, lncRNA tumor suppressor candidate 7 (TUSC7) has been identified as a tumor suppressor gene.
Xu‐Li Wang, Jia Mei
wiley   +1 more source

Complex presentation of polyarteritis nodosa: Renal pseudoaneurysm rupture and bowel ischemia: A case report. [PDF]

Int J Surg Case Rep
Rabaya AF, Ibraheem K, Shawer O, Nairat MN, Sayes S, Salhab R.   +5 more
europepmc   +1 more source

Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC 409962) and cyclophosphamide therapy of drug-resistant metastatic breast carcinoma [PDF]

, 1977
Cary A. Presant, Albert Van Amburg, Carol Klahr   +2 more
openalex   +1 more source

Neoplasia and Cyclophosphamide [PDF]

Arthritis & Rheumatism, 1973
Bertrand L. Stolzer, James H. Barr, Burton H. Pollock, Amrit Agarwal, Harry M. Margolis, Carl H. Eisenbeis   +5 more
openaire   +2 more sources

Expression and Clinical Significance of CXCR5 and LAG‐3 on Peripheral Blood CD8+ T Cells in Patients With Diffuse Large B‐Cell Lymphoma

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Diffuse large B‐cell lymphoma (DLBCL) exhibits substantial biological and clinical heterogeneity. This study investigated the expression and prognostic implications of C‐X‐C chemokine receptor type 5 (CXCR5) and lymphocyte activation gene‐3 (LAG‐3) on peripheral blood CD8+ T cells in patients with DLBCL.
Xi‐Zhe Guo, Ya‐Fei Guo, Shi‐Xin Wu
wiley   +1 more source

Oral Cyclophosphamide for Patients With Metastatic Castration-Resistant Prostate Cancer in a Scenario of Limited Health Care Resources. [PDF]

JCO Glob Oncol
Pineda DDC, Polho GB, Shinkado YR, Contado GA, Crusoe NS, Horita VN, Resende JC, Silva JA, de Freitas GF, Muniz DQ, Suartz CV, Ribeiro-Filho LA, Hoff PM, Mota JM.   +13 more
europepmc   +1 more source

Adriamycin, BCNU plus cyclophosphamide (ABC) in advanced carcinoma of the head and neck [PDF]

, 1979
Cary A. Presant, Gary Ratkin, Carol Klahr, Carol Brown   +3 more
openalex   +1 more source

Histological Type‐Specific Behavior in Sarcomas: Analysis of Head and Neck Cancer Registry of Japan

The Laryngoscope, EarlyView.
The nasal cavity and paranasal sinuses are the most common sites for sarcomas of the head and neck, and predominant histological type depended on the primary site. Objective The goal of this study was to better understand the epidemiology, clinical characteristics, and treatment outcomes of head and neck sarcomas using real‐world data from Japan ...
Kenya Kobayashi, Seiichi Yoshimoto, Koji Yamamura, Megumi Kitayama, Daisuke Kawakita, Ken‐Ichi Nibu, Kenji Kondo, Yuki Saito   +7 more
wiley   +1 more source

Cardiotoxicity of breast cancer drug treatments. [PDF]

Transl Oncol
Haque M, Atallah N, Patke R, Harris AE, Woodcock CL, Varun D, Thompson RL, Jackson-Oxley J, Okui CH, Dean A, Alsaleem M, Rakha E, Irshad S, Davis MB, Jeyapalan JN, Mongan NP, Rutland CS.   +16 more
europepmc   +1 more source

Letter: Cyclophosphamide in treatment of nephrotic syndrome. [PDF]

, 1975
L.S. Ibels, Andrew Palmer, J. F. Mahony, J. H. Stewart   +3 more
openalex   +1 more source